UA84270C2 - Жидкая фармацевтическая композиция для орального применения, которая содержит связанный с ионообменной смолой прадофлоксацин и структурно-вяжущие гелеобразователи - Google Patents

Жидкая фармацевтическая композиция для орального применения, которая содержит связанный с ионообменной смолой прадофлоксацин и структурно-вяжущие гелеобразователи

Info

Publication number
UA84270C2
UA84270C2 UA20041210942A UA20041210942A UA84270C2 UA 84270 C2 UA84270 C2 UA 84270C2 UA 20041210942 A UA20041210942 A UA 20041210942A UA 20041210942 A UA20041210942 A UA 20041210942A UA 84270 C2 UA84270 C2 UA 84270C2
Authority
UA
Ukraine
Prior art keywords
oral administration
pharmaceutical preparations
active ingredients
exchange resins
gelling agents
Prior art date
Application number
UA20041210942A
Other languages
English (en)
Ukrainian (uk)
Inventor
Дирк Мертин
Маркус Эдингло
Герт Даубе
Original Assignee
Байер Хэлскер Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Хэлскер Аг filed Critical Байер Хэлскер Аг
Publication of UA84270C2 publication Critical patent/UA84270C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Данное изобретение касается жидкой фармацевтической композиции, которая содержит прадофлоксацин, связанный с ионообменником, причем заряженный ионообменник диспергирован в среде-носителе, которая содержит воду и один или несколько структурно-вяжущих гелеобразователей.
UA20041210942A 2002-05-31 2003-05-19 Жидкая фармацевтическая композиция для орального применения, которая содержит связанный с ионообменной смолой прадофлоксацин и структурно-вяжущие гелеобразователи UA84270C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10224086A DE10224086A1 (de) 2002-05-31 2002-05-31 Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
PCT/EP2003/005228 WO2003101422A2 (de) 2002-05-31 2003-05-19 Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker

Publications (1)

Publication Number Publication Date
UA84270C2 true UA84270C2 (ru) 2008-10-10

Family

ID=29432468

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20041210942A UA84270C2 (ru) 2002-05-31 2003-05-19 Жидкая фармацевтическая композиция для орального применения, которая содержит связанный с ионообменной смолой прадофлоксацин и структурно-вяжущие гелеобразователи

Country Status (28)

Country Link
US (1) US8545829B2 (ru)
EP (1) EP1513500B1 (ru)
JP (2) JP5350574B2 (ru)
KR (3) KR20050010015A (ru)
CN (1) CN1671361B (ru)
AR (2) AR039861A1 (ru)
AT (1) ATE421317T1 (ru)
AU (1) AU2003242545B2 (ru)
BR (2) BR0311511A (ru)
CA (1) CA2487648C (ru)
CR (1) CR7598A (ru)
DE (2) DE10224086A1 (ru)
DK (1) DK1513500T3 (ru)
ES (1) ES2319115T3 (ru)
HK (1) HK1083200A1 (ru)
HR (1) HRP20041219B1 (ru)
IL (2) IL165322A0 (ru)
MX (1) MXPA04011820A (ru)
MY (1) MY140953A (ru)
NO (1) NO333939B1 (ru)
PL (1) PL207269B1 (ru)
PT (1) PT1513500E (ru)
RU (1) RU2380091C2 (ru)
SI (1) SI1513500T1 (ru)
TW (1) TWI333422B (ru)
UA (1) UA84270C2 (ru)
WO (1) WO2003101422A2 (ru)
ZA (1) ZA200409616B (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
WO2006061700A2 (en) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
DE102005025900A1 (de) * 2005-06-06 2006-12-07 Basf Ag Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
US20070248564A1 (en) * 2006-04-25 2007-10-25 Roxane Laboratories, Inc. Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia
EP2066302A2 (en) 2006-09-26 2009-06-10 Taro Pharmaceuticals North America, Inc. Stabilizing compositions for antibiotics and methods of use
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
US20090247575A1 (en) * 2008-03-26 2009-10-01 Taro Pharmaceuticals North America, Inc. Stabilizing lipid compositions for oral pharmaceutical agents
LT2544532T (lt) 2010-03-12 2017-06-12 Monsanto Technology Llc Agrocheminių gelių kompozicijos
PL2572717T3 (pl) * 2010-05-19 2016-12-30 Kompozycja farmaceutyczna zawierająca solifenacynę
WO2013058996A1 (en) 2011-10-19 2013-04-25 R.P. Scherer Technologies, Llc Two phase pharmaceutical delivery system
FR2998305B1 (fr) * 2012-11-22 2015-02-20 Henkel Ag & Co Kgaa Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire
KR101697095B1 (ko) * 2015-09-30 2017-01-18 주식회사 포스코 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크
CA3098060A1 (en) 2018-04-25 2019-10-31 Bayer Animal Health Gmbh Process for the hydrolysis of quinolone carboxylic esters
CN114249749B (zh) * 2022-01-08 2024-03-22 天象生物药业邢台有限责任公司 一种马波沙星甲酸盐的转化方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60204713A (ja) 1984-03-30 1985-10-16 Zenyaku Kogyo Kk 水性懸濁組成物
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5338732A (en) * 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
CA2117266C (en) * 1991-10-28 1998-01-06 John Robert Bunger Beverage thickener/emulsifier system
JP3207494B2 (ja) * 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
JP4338217B2 (ja) * 1996-02-23 2009-10-07 バイエル・アニマル・ヘルス・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 置換可能な８―シアノ―１―シクロプロピル―７―（２，８―ジアザビシクロ―［４．３．０］―ノナン―８―イル）―６―フルオロ―１，４―ジヒドロ―４―オキソ―３―キノリンカルボン酸およびそれらの誘導体
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
EP1200129B1 (en) * 1999-07-14 2008-10-15 Schering-Plough Ltd. Taste masking of oral quinolone liquid preparations using ion exchange resins
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10134719A1 (de) * 2001-07-17 2003-02-06 Bayer Ag Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze
US7001667B2 (en) * 2002-07-17 2006-02-21 Ppg Industries Ohio, Inc. Alkyd-based free radical wood coating compositions

Also Published As

Publication number Publication date
PL207269B1 (pl) 2010-11-30
IL165322A (en) 2015-11-30
CR7598A (es) 2008-07-31
AU2003242545A1 (en) 2003-12-19
CN1671361B (zh) 2010-05-12
AU2003242545B2 (en) 2010-02-18
PL373456A1 (en) 2005-08-22
HK1083200A1 (en) 2006-06-30
HRP20041219A2 (en) 2006-02-28
EP1513500A2 (de) 2005-03-16
ZA200409616B (en) 2006-05-31
RU2380091C2 (ru) 2010-01-27
AR039861A1 (es) 2005-03-02
SI1513500T1 (sl) 2009-06-30
TWI333422B (en) 2010-11-21
BRPI0311511B1 (pt) 2018-07-10
JP2006503806A (ja) 2006-02-02
BRPI0311511A (ru) 2005-02-22
HRP20041219B1 (hr) 2013-05-31
DE10224086A1 (de) 2003-12-11
NO333939B1 (no) 2013-10-28
US8545829B2 (en) 2013-10-01
BR0311511A (pt) 2005-02-22
CA2487648C (en) 2012-03-13
KR20120123607A (ko) 2012-11-08
BRPI0311511A8 (pt) 2017-07-11
ATE421317T1 (de) 2009-02-15
KR20120006092A (ko) 2012-01-17
DE50311123D1 (de) 2009-03-12
KR20050010015A (ko) 2005-01-26
IL165322A0 (en) 2006-01-15
WO2003101422A3 (de) 2004-12-09
MY140953A (en) 2010-02-12
CA2487648A1 (en) 2003-12-11
WO2003101422A2 (de) 2003-12-11
MXPA04011820A (es) 2005-03-31
NO20045700L (no) 2004-12-29
TW200406230A (en) 2004-05-01
EP1513500B1 (de) 2009-01-21
US20060177414A1 (en) 2006-08-10
JP5350574B2 (ja) 2013-11-27
ES2319115T3 (es) 2009-05-04
CN1671361A (zh) 2005-09-21
RU2004139022A (ru) 2005-07-10
AR105798A2 (es) 2017-11-08
PT1513500E (pt) 2009-04-02
KR101258373B1 (ko) 2013-04-30
JP2011012087A (ja) 2011-01-20
DK1513500T3 (da) 2009-05-11

Similar Documents

Publication Publication Date Title
HK1083200A1 (en) Pharmaceutical preparations for oral administration, containing ion- exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
BR0015188A (pt) Composições farmacêuticas
HK1096034A1 (en) A solid dosage form comprising a fibrate
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
BR0211198A (pt) Composições farmacêuticas e seu uso
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
YU8701A (sh) Nova oralna kompozicija
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
HK1045937B (zh) 用於口服間苯三酚的藥物組合物及其製備方法
DE602004017514D1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
MXPA04002099A (es) Composiciones medicinales para neuropatia diabetica.
AU6308800A (en) Pharmaceutical composition and preparation thereof
AR006034A1 (es) Una composicion antitranspirante, un sistema antitranspirante que la comprende y la utilizacion de un emoliente en la preparacion de la misma
ECSP993210A (es) Preparado farmaceutico de moxifloxacina (lea 33327-ec)
EG24704A (en) A method for the preparation of stable pharmaceutical compositions for intramusclar injection, combining folic acid with other vitamins in a single aqueous solution
HRPK20040924B3 (en) Preparation based on curcumae longae rhizomae roots
TW200626577A (en) Compounds, compositions containing them, preparation thereof and uses thereof